Gene therapy holds promise for rare form of color blindness

04/23/2010 | United Press International

U.S. scientists said they were able to re-establish cone function in two dogs with congenital achromatopsia, a rare genetic disorder that causes color blindness, after treating them with recombinant adeno-associated virus-mediated gene therapy. The disease affects about 1 in 50,000 people.

View Full Article in:

United Press International

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
Springfield, OR
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA